Background
In 2013 more than 7.4 million American adults had psoriasis (PsO), a chronic inflammatory skin disease.1 Comorbid conditions associated with PsO cost the healthcare system approximately $36.4 billion each year as of 2013,2 and the serious infections that occur with PsO can increase hospital length of stays and mortality rates. Psoriasis is treated by therapeutics that can help to decrease inflammation and symptoms.3
Peyerl and colleagues conducted a retrospective study to analyze comorbidities and infections among patients with PsO, as well as therapeutic options used by these patients.3
Methods
Peyerl and colleagues used data from an electronic health record database to study the comorbidities, infections, and therapeutics of adult patients with PsO between 2012 and 2016. Comorbidities and infections were identified through International Classification of Diseases, Ninth and Tenth revisions, Clinical Modification codes; treatments such as topical applications, light therapy, and medications were identified through procedure codes and medication names.3
Results
Of the 244,512 PsO-related visits evaluated in the study, the most common comorbidities presented were psoriatic arthritis (21.7%), type 2 diabetes (12.2%), kidney disease (4.5%), and cardiovascular disease (3.9%). The most frequent infections were skin infections (2.7%), fungal infections (2.1%), urinary tract infections (2%), hepatitis C (1.4%), upper respiratory infections (1.4%), pneumonia (1.13%), herpes zoster (0.16%), hepatitis B (0.12%), and tuberculosis (0.03%). Regarding types of therapies prescribed, 56.5% of the records from patient visits indicated the use of topical treatments; 25.3% indicated light therapy; and 18.2% indicated systemic medications, including methotrexate (67.2%), biologics (15.6%), and retinoids (4.7%).4
Conclusions
Based on this analysis, comorbidities associated with PsO were shown to be common; psoriatic arthritis was the most prevalent comorbid condition experienced by patients with PsO. Infections, which can contribute to increased hospital days and mortality rates, were also prevalent, with skin and fungal infections being most common. Patients with PsO received topical therapies 2 times more frequently than light therapy and 3 times more frequently than systemic medication prescriptions. The most frequently prescribed systemic medication was methotrexate.3
References
1. Rachakonda TD, Schupp CW, Armstrong AW. Psoriasis prevalence among adults in the United States. J Am Acad Dermatol. 2014;70(3):512-516. doi: 10.1016/j.jaad.2013.11.013.
2. Brezinski EA, Dhillon JS, Armstrong AW. Economic burden of psoriasis in the United States: a systematic review. JAMA Dermatol. 2015;151(6):651-658. doi: 10.1001/jamadermatol.2014.3593.
3. Peyerl FW, Varsos GV, Shen M, et al. Comorbidities, infections and treatment patterns in psoriasis patients: a retrospective analysis of a large US electronic health record database. Poster presented at: ISPOR 2019; May 18-22, 2019; New Orleans, LA. ispor.org/heor-resources/presentations-database/presentation/intl2019-2217/91304.
4. Peyerl FW, Varsos GV, Shen M, et al. Comorbidities, infections and treatment patterns in psoriasis patients: a retrospective analysis of a large US electronic health record database. Value Health. 2019;22(2):S378. doi: 10.1016/j.jval.2019.04.1844.
Beyond the Surface: How New Therapies, Patient-Centered Care Are Changing Psoriasis Outcomes
August 19th 2025National Psoriasis Awareness Month offers an opportunity to examine how advances in systemic therapy, combined with patient-centered care models, are reshaping the treatment landscape.
Read More
The Breakdown: Breast Cancer Research Awareness Day
August 19th 2025Breast cancer is the second most common cancer among women and the second leading cause of cancer-related deaths among women in the US. In light of Breast Cancer Research Awareness Day, The American Journal of Managed Care® breaks down the most recent advancements in breast cancer prevention, screening, and therapies.
Listen
Psoriasis as an Inflammatory Disease, and What’s Changed Over Time
August 3rd 2021August is National Psoriasis Awareness Month, and on this episode of Managed Care Cast, we bring you an excerpt of an interview with a New Jersey dermatologist about the changing concept of psoriasis as more than just a skin disease.
Listen
Finerenone Demonstrates Safety and Efficacy in Heart Failure When Combined With Diuretics
August 13th 2025Clinical trial results establish the safety and efficacy of finerenone to help preserve potassium levels and reduce sodium in patients on diuretics with heart failure and mildly reduced ejection fraction or preserved ejection fraction.
Read More
Genetics, Comorbidities Associated With Cardiomyopathy and Atrial Fibrillation
August 13th 2025The cause of dilated cardiomyopathy (DCM) can be associated with the presence of the TTN gene combined with preexisting comorbidities like atrial fibrillation, which increase the odds of developing DCM.
Read More